Skip to main content

Media

The following information is intended as a resource for journalists only and was factually correct at the time it was issued. For up to date safety information please refer to current consumer medicine information and product information.

For media-related enquiries, please contact

Corporate Communications
Australia and New Zealand
[email protected]

2023

May

Experts meet to spur on New Zealand’s hepatitis C elimination plan
Read full media release here.

2022

July

5,000 New Zealanders have now received funded access to MAVIRET for the treatment of hepatitis C
Read full media release here.

May

AbbVie appoints Kylie Pennington as Country Head, New Zealand
Read full media release here.

2021

September

Pharmac funds additional treatment option for eligible New Zealanders living with rheumatoid arthritis
Read full media release here.

2020

May

AbbVie Completes Transformative Acquisition of Allergan
Read full media release here.

March

AbbVie New Zealand - Local Response to COVID-19 
Read here.

2019

December

Chris Stemple Appointed General Manager AbbVie ANZ
Read full media release here.

October

PHARMAC funds new treatment option for New Zealanders living with chronic lymphocytic leukaemia
Read full media release here.

October

PHARMAC funds new treatment option for New Zealanders living with painful inflammatory skin condition
Read full media release here.

September

PHARMAC Funds Treatment for a Leading Cause of Preventable Blindness
Read full media release here.

June

AbbVie ANZ Appoints New Medical Director
Read full media release here.

February

New treatment available to New Zealanders seeking a viral cure for Hepatitis C
Read full media release here.